Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference17 articles.
1. McClellan K, Perry CM (2001) Oseltamivir: a review of its use in influenza. Drugs 61:263–283
2. Wiltshire H, Wiltshire B, Citron A, Clarke T, Serpe C, Gray D, Herron W (2000) Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B Biomed Sci Appl 745:373–388
3. Dreitlein WB, Maratos J, Brocavich J (2001) Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza. Clin Ther 23:327–355. doi: 10.1016/S0149-2918(01)80042-4
4. Nicholson KG, Aoki FY, Osterhaus ADME, Trottier S, Carewicz O, Mercier CH et al (2000) Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 355:1845–1850. doi: 10.1016/S0140-6736(00)02288-1
5. Eisenberg EJ, Cundy KC (1998) High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehyde. J Chromatogr B Biomed Sci Appl 716:267–273. doi: 10.1016/S0378-4347(98)00268-0
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献